Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_assertion type Assertion NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_head.
- NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_assertion description "[Furthermore, methylation-dependent silencing of SOX11 has been reported for B cell lymphomas and indicates that epigenetic drugs may be used to re-express this tumour suppressor, but information on SOX11 promoter methylation in EOC is still lacking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_provenance.
- NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_assertion evidence source_evidence_literature NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_provenance.
- NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_assertion SIO_000772 21943380 NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_provenance.
- NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_assertion wasDerivedFrom befree-20150227 NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_provenance.
- NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_assertion wasGeneratedBy ECO_0000203 NP709080.RAkY9eq1nsg_ivhLQI0BSLokzdQswQF5goUpWEvsJbZ_k130_provenance.